The global development of a biosimilar product is a methodologically complex affair, lined with potential design pitfalls and operational missteps to be avoided. Read this article for design options for clinical efficacy studies.
Key design considerations on comparative clinical efficacy studies for biosimilars
Adalimumab as an example
Read more